eISSN: 1994-4624 / ISSN: 1813-176x
Register
Login
International Journal of Molecular Medicine and Advance Sciences
2020, Volume 16, Issue 1 : 26-31
Research Article
Hybrid Coronary Revascularization Approaches: A Comprehensive Clinical Outcome Review
 ,
 ,
1
Department of Cardiothoracic Surgery, Crescent Heart Institute, New Delhi, India
2
Division of Interventional Cardiology, GlobalCare Medical Center, Singapore
3
Department of Medical Biostatistics, Oxford College of Health Sciences, UK
Received
March 23, 2020
Revised
April 12, 2020
Accepted
May 19, 2020
Published
June 30, 2020
Abstract

Hybrid Coronary Revascularization (HCR) combines minimally invasive coronary artery bypass grafting (CABG), typically using a left internal mammary artery (LIMA) graft to the left anterior descending artery (LAD), with percutaneous coronary intervention (PCI) using drug-eluting stents (DES) for non-LAD lesions. This approach aims to merge the benefits of durable surgical grafts with reduced procedural morbidity and faster recovery associated with PCI. This study evaluates clinical outcomes, mortality, long-term patency, and repeat revascularization rates in 1,070 patients who underwent HCR across three tertiary centers over six years. HCR demonstrated lower repeat revascularization (11.4%) compared to conventional CABG alone (15.7%) and multi-vessel PCI (22.3%). Hospital stay duration and intensive care utilization were significantly reduced. The findings support HCR as a viable alternative for multi-vessel coronary artery disease, particularly in high-risk patients.

Keywords
License
Copyright (c) International Journal of Molecular Medicine and Advance Sciences
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
Int. J. Mol. Med. Adv. Sci. open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Recommended Articles
Mental Health Awareness and Help-Seeking Behavior: A Comprehensive Study of Knowledge, Attitudes, Barriers, and Interventions
7-12
Impact of Climate Change on Human Health
20-26
Healthcare Disparities and Equity in Medical Services: Challenges, Determinants, and Strategies for Achieving Equitable Healthcare
27-34
Clinical Efficacy of Drug-Eluting Stents Among Hypertensive Patients
41-45
International Journal of Molecular Medicine and Advance Sciences
+447480266638
+447480266638
support@ijmmas.com
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives (CC BY-NC-ND) license. Open Access Publication.
Copyright © ©International Journal of Molecular Medicine and Advance Sciences. All rights reserved.